O.‐E. Brodde

2.6k total citations
41 papers, 2.1k citations indexed

About

O.‐E. Brodde is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, O.‐E. Brodde has authored 41 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 13 papers in Cardiology and Cardiovascular Medicine and 13 papers in Physiology. Recurrent topics in O.‐E. Brodde's work include Receptor Mechanisms and Signaling (25 papers), Pharmacological Effects and Assays (10 papers) and Adipose Tissue and Metabolism (6 papers). O.‐E. Brodde is often cited by papers focused on Receptor Mechanisms and Signaling (25 papers), Pharmacological Effects and Assays (10 papers) and Adipose Tissue and Metabolism (6 papers). O.‐E. Brodde collaborates with scholars based in Germany, United States and Netherlands. O.‐E. Brodde's co-authors include Martin C. Michel, M. C. Michel, Paul A. Insel, Gerd Heusch, H.-R. Zerkowski, H.–R. Zerkowski, C Martín, Johnie Rose, Rainer Schulz and A Daul and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

O.‐E. Brodde

41 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O.‐E. Brodde Germany 23 1.1k 1.1k 508 419 232 41 2.1k
Shigetoshi Chiba Japan 24 1.6k 1.5× 1.5k 1.3× 887 1.7× 922 2.2× 97 0.4× 409 3.5k
Jan‐Bjørn Osnes Norway 26 880 0.8× 978 0.9× 294 0.6× 265 0.6× 86 0.4× 84 1.7k
B B Hoffman United States 20 417 0.4× 742 0.7× 540 1.1× 416 1.0× 70 0.3× 32 1.8k
Tor Skomedal Norway 25 975 0.9× 1.0k 0.9× 248 0.5× 282 0.7× 78 0.3× 75 1.6k
Ernst Bürgisser Switzerland 18 654 0.6× 590 0.5× 226 0.4× 259 0.6× 52 0.2× 25 1.7k
Rosemary D. Bevan United States 25 445 0.4× 531 0.5× 633 1.2× 382 0.9× 51 0.2× 72 1.9k
Ben G. Zimmerman United States 20 980 0.9× 483 0.4× 308 0.6× 262 0.6× 67 0.3× 98 1.7k
Claudio de Lucia Italy 27 829 0.7× 799 0.7× 378 0.7× 164 0.4× 40 0.2× 53 1.9k
Koroku Hashimoto Japan 20 754 0.7× 515 0.5× 291 0.6× 241 0.6× 47 0.2× 152 1.6k
Gert Richardt Germany 27 1.4k 1.3× 761 0.7× 224 0.4× 378 0.9× 28 0.1× 111 2.3k

Countries citing papers authored by O.‐E. Brodde

Since Specialization
Citations

This map shows the geographic impact of O.‐E. Brodde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O.‐E. Brodde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O.‐E. Brodde more than expected).

Fields of papers citing papers by O.‐E. Brodde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O.‐E. Brodde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O.‐E. Brodde. The network helps show where O.‐E. Brodde may publish in the future.

Co-authorship network of co-authors of O.‐E. Brodde

This figure shows the co-authorship network connecting the top 25 collaborators of O.‐E. Brodde. A scholar is included among the top collaborators of O.‐E. Brodde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O.‐E. Brodde. O.‐E. Brodde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brodde, O.‐E. & Th. Philipp. (2006). Bedeutung des L-Arginin/NO-Systems für die Wirkung von Nebivolol. DMW - Deutsche Medizinische Wochenschrift. 131(45). 2545–2550. 1 indexed citations
2.
Drexler, Helmut, et al.. (1998). Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. Journal of the American College of Cardiology. 32(4). 955–963. 140 indexed citations
3.
Schäfers, Rainhild, et al.. (1997). Influence of adrenoceptor and muscarinic receptor blockade on the cardiovascular effects of exogenous noradrenaline and of endogenous noradrenaline released by infused tyramine. Naunyn-Schmiedeberg s Archives of Pharmacology. 355(2). 239–249. 57 indexed citations
4.
Brodde, O.‐E.. (1995). Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovascular Research. 30(4). 570–584. 47 indexed citations
5.
Brodde, O.‐E., A Daul, M. C. Michel, & H.–R. Zerkowski. (1992). Bedeutung von β2-Adrenozeptoren bei Herzinsuffizienz. Zeitschrift für Kardiologie. 81(4). 71–78. 4 indexed citations
6.
Brodde, O.‐E., et al.. (1992). Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure.. PubMed. 11(4 Pt 2). S164–74. 37 indexed citations
7.
Zerkowski, H.–R., et al.. (1991). Development of  -adrenoceptor number and subtype distribution in the transplanted human heart. European Heart Journal. 12(suppl F). 124–126. 6 indexed citations
8.
Michel, M. C., Alan Maisel, & O.‐E. Brodde. (1990). Mitigation of β1- and/or β2-adrenoceptor function in human heart failure. British Journal of Clinical Pharmacology. 30. 10 indexed citations
9.
Brodde, O.‐E.. (1990). Circulating blood cells: a suitable tool to investigate human cardiovascular pharmacology?. European Journal of Pharmacology. 183(1). 152–152. 1 indexed citations
10.
Tits, Lambertus J.H. van, A Daul, H. Grosse‐Wilde, et al.. (1990). Effects of Insulin-Induced Hypoglycemia onβ2-Adrenoceptor Density and Proliferative Responses of Human Lymphocytes*. The Journal of Clinical Endocrinology & Metabolism. 71(1). 187–192. 9 indexed citations
11.
Brodde, O.‐E., A Daul, & M. C. Michel. (1990). Subtype-selective modulation of human beta 1- and beta 2-adrenoceptor function by beta-adrenoceptor agonists and antagonists.. PubMed. 8 Suppl 2. 11–7. 24 indexed citations
12.
Motomura, Shigeru, N.M. Deighton, H.–R. Zerkowski, et al.. (1990). Chronic β1‐adrenoceptor antagonist treatment sensitizes β2‐adrenoceptors, but desensitizes M2‐muscarinic receptors in the human right atrium. British Journal of Pharmacology. 101(2). 363–369. 72 indexed citations
13.
Michel, Martin C. & O.‐E. Brodde. (1989). Lymphocyte adenylate cyclase activity in immunosuppressed patients. European Journal of Clinical Pharmacology. 37(1). 41–43. 5 indexed citations
14.
Brodde, O.‐E., et al.. (1989).  -adrenoceptor regulation in the human heart: can it be monitored in circulating lymphocytes?. European Heart Journal. 10(suppl B). 2–10. 60 indexed citations
15.
Michel, Martin C., et al.. (1988). Selective regulation of β1‐and β2‐adrenoceptors in the human heart by chronic β‐adrenoceptor antagonist treatment. British Journal of Pharmacology. 94(3). 685–692. 93 indexed citations
16.
Michel, Martin C., et al.. (1987). Increased β2‐adrenoreceptor density in heart, kidney and lung of spontaneously hypertensive rats. Journal of Autonomic Pharmacology. 7(1). 41–52. 36 indexed citations
17.
Ikezono, Katsumi, H.–R. Zerkowski, J. J. Beckeringh, M. C. Michel, & O.‐E. Brodde. (1987). Beta-2 adrenoceptor-mediated relaxation of the isolated human saphenous vein.. Journal of Pharmacology and Experimental Therapeutics. 241(1). 294–299. 30 indexed citations
18.
Brodde, O.‐E., et al.. (1985). Alpha- and Beta-Adrenoceptors in Circulating Blood Cells of Essential Hypertensive Patients: Increased Receptor Density and Responsiveness. Clinical and Experimental Hypertension Part A Theory and Practice. 7(8). 1135–1150. 34 indexed citations
19.
Brodde, O.‐E., A Daul, Naoki Ohara, & K. D. Bock. (1984). Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients.. PubMed. 2(3). S111–4. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigetoshi Chiba Breakdown of academic impact, for papers by Jan‐Bjørn Osnes Breakdown of academic impact, for papers by B B Hoffman Breakdown of academic impact, for papers by Tor Skomedal Breakdown of academic impact, for papers by Ernst Bürgisser Breakdown of academic impact, for papers by Rosemary D. Bevan Breakdown of academic impact, for papers by Ben G. Zimmerman Breakdown of academic impact, for papers by Claudio de Lucia Breakdown of academic impact, for papers by Koroku Hashimoto Breakdown of academic impact, for papers by Gert Richardt
Rankless by CCL
2026